BMED Stock iShares Health Innovation Active ETF (BMED) (BMED, $33.77) Moving Average Convergence Divergence (MACD) Histogram turned negative on October 1, 2026
at Tickeron.com
This is a Bearish indicator signaling BMED's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 45 similar cases where BMED's MACD histogram became negative, and of them led to successful outcomes. Odds of Success:
BMED in -1.29% downward trend, declining for three consecutive days on October 13, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BMED declined for three days, in 216 of 279 cases, the price declined further within the following month. The odds of a continued downward trend are 77%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on BMED as a result. In 69 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for BMED just turned positive on October 15, 2026. Looking at past instances where BMED's MACD turned positive, the stock continued to rise in 33 of 45 cases over the following month. The odds of a continued upward trend are 73%.
Following a +3.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMED advanced for three days, in 226 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.